Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.

Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list. Abstract Text:

B-H Ferraz-Neto,R Hidalgo,T ,V A Melo,A Lobue,M P V C Zurstrassen,J M Moraes,S P Meira-Filho,M B Rezende,L E P Fonseca,F L Pandullo,F S Soeiro,R C Afonso,B-H Ferraz-Neto,R Hidalgo,T ,V A Melo,A Lobue,M P V C Zurstrassen,J M Moraes,S P Meira-Filho,M B Rezende,L E P Fonseca,F L Pandullo,F S Soeiro,R C Afonso,

BACKGROUND: The Model for End-Stage Liver Disease (MELD) was introduced in 1999 to quantify the 3-month prognosis of cirrhotic patients after a transjugular intrahepatic portosystemic shunt (TIPS). Because of the imbalance between organ donors and patients on the waiting list, the MELD was adopted by the United States in 2002 to allocate liver grafts for transplantation. Preliminary results have indicated a reduction in waiting list deaths and an increase in transplantation rates for candidates. Seeking to find a new model to predict death on the waiting list and after liver transplantation, retrospective studies have examined MELD scores in waiting list patients. The aim of this study was to analyze the MELD scores of patients on the liver waiting list for comparisons between transplanted patients. PATIENTS AND METHODS: A retrospective study was performed analyzing 131 registrations of 127 orthotopic liver transplant (OLT) patients (4 underwent retransplantation) grafted between November 2000 and January 2006, excluding 24 patients: 2 had urgent retransplantations due to hepatic artery thrombosis and 22 had incomplete data. These patients were divided into 3 groups: group I (transplanted patients)-53 patients underwent 55 OLT; group II-29 patients who died on the waiting list; group III-patients on the waiting list including 23 patients still waiting as of the date of the study. RESULTS: The main indication for OLT was hepatitis C virus cirrhosis (50.50%), followed by alcoholic liver cirrhosis (23.30%), cryptogenic cirrhosis (12.60%), autoimmune hepatitis (5.80%), hepatitis B virus cirrhosis (4.85%), and primary biliary cirrhosis (2.91%). Group I: MELD score 15.62 (range, 6-39) on admission to the list, and 18.87 (range, 7-39) at transplantation. The mean waiting time for OLT was 478.39 days (range, 2-1270 days). The 38 patients who survived underwent 39 OLT (1 retransplantation). The MELD score at entrance to the list was 14.62 (range, 7-30) and at transplantation, 17.70 (range, 7-39). The mean time between admission to the list and transplantation was 505.37 days (range, 6-1270 days). The 15 patients who died had received 16 OLT (1 retransplantation). Their MELD scores were 17.80 (range, 6-39) and 21.81 (range, 9-39) at admission to the list and at transplantation, respectively, with a mean time on the waiting list of 417.93 days (range, 2-872 days). Group II: 29 patients died before OLT, at a mean age of 52.60 years (range, 22-67 years). Their MELD score was 19.24 (range, 7-45), and the interval between admission to the waiting list and death was 249.55 days (range, 3-1247 days). Group III: 23 patients still active on the OLT waiting list at the time of study displayed a mean MELD score of 13.65 (range, 6-28) and 354.30 days (range, 2-905 days) waiting until the moment. In conclusion, MELD score at the time of admission to the waiting list was higher among those patients who died either awaiting a liver graft (19.24) or after OLT (17.80) compared with those who survived after OLT (14.60) or are still awaiting OLT (13.65).

Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list. Publishing Authors By Initials

BH Ferraz-Neto,R Hidalgo,T ,VA Melo,A Lobue,MP Zurstrassen,JM Moraes,SP Meira-Filho,MB Rezende,LE Fonseca,FL Pandullo,FS Soeiro,RC Afonso,BH Ferraz-Neto,R Hidalgo,T ,VA Melo,A Lobue,MP Zurstrassen,JM Moraes,SP Meira-Filho,MB Rezende,LE Fonseca,FL Pandullo,FS Soeiro,RC Afonso,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Transplantation proceedings

VOLUME: 39

Page Numbers: 2511-3

Journal Abbreviation: Transplant. Proc.

ISSN: 0041-1345

DAY: 23

MONTH: Oct

YEAR: 2007

Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 243532

Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.

AFFILIATION: Figado HIAE, Albert Einstein Jewish Hospital, Av. Albert Einstein 627/701, 05652-900 São Paulo/SP, Brazil. ben-hur@einstein.br

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Transplant Proc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Analysis of Model for End-Stage Liver Disease MELD score in a liver transplantation waiting list Related Publications

• A comparative study on absorption and selectivity of organic vapors by using ionic liquids based on imidazolium, quaternary ammonium, and guanidinium cations.
• Acute pulmonary edema following pericardiocentesis for cardiac tamponade.
• Analysis of Liver Transplantation Outcome in Patients With MELD Score >/=30.
• Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
• Analytical methods applied to the determination of heterocyclic aromatic amines in foods.
• Classical swine fever virus inhibits nitric oxide production in infected macrophages.
• Comparison of physicochemical properties of new ionic liquids based on imidazolium, quaternary ammonium, and guanidinium cations.
• Complex endocarditis in an immunocompromised host: the role of three-dimensional echocardiography.
• Correlation between graft arterial anatomy and biliary complications after liver transplantation.
• Cortisol response and immune-related effects of Atlantic salmon (Salmo salar Linnaeus) subjected to short- and long-term stress.
• Critical separation for efficient Tm(3+)-Tm(3+) energy transfer evidenced in nanostructured Tm(3+):Al(2)O(3) thin films.
• Dental services in Goa, Daman & Diu (India).
• Dioxins sources and current remediation technologies - A review.
• Donor liver dysfunction: application of a new scoring system to identify the marginal donor.
• Exposure to heterocyclic aromatic amines from the consumption of cooked red meat and its effect on human cancer risk: A review.
• Fluid-particle separation in a random flow described by the telegraph model.
• Impairment of the stress response in matrinxã juveniles (Brycon amazonicus) exposed to low concentrations of phenol.
• Microwave accelerated facile synthesis of fused polynuclear hydrocarbons in dry media by intramolecular Friedel-Crafts alkylation.
• Myocardial infarction with angiographically normal coronary arteries in the contemporary era.
• One-Pot Enzymatic Resolution and Separation of sec-Alcohols Based on Ionic Acylating Agents.
• Phylogenetic diversity among low-virulence newcastle disease viruses from waterfowl and shorebirds and comparison of genotype distributions to those of poultry-origin isolates.
• Primary chicken tracheal cell culture system for the study of infection with avian respiratory viruses.
• Recovery of valuable elements from spent Li-batteries.
• Severity of coronary artery disease in obese patients undergoing coronary angiography: "obesity paradox" revisited.
• The ionic liquid 1-hexadecyl-3-methylimidazolium bromide as novel extracting system for polycyclic aromatic hydrocarbons contained in sediments using focused microwave-assisted extraction.
• Thromboembolic complications of left ventricular noncompaction: case report and brief review of the literature.
• [Bronchopulmonary carcinoid tumor; a challenge]
• [Pulmonary carcinoid cancers.]
• [Retrospective analysis of patients with non-small cell lung cancer in surgical stage.]
• [Risk of pulmonary complications after elective surgery.]